Last reviewed · How we verify
Bacterial infection of skin
Approved treatments
- Ramycin
Fusidic acid works by inhibiting the function of the bacterial ribosome, preventing the production of essential proteins. - Garamycin · Merck & Co.
- Dalvance · AbbVie
Dalvance works by binding to the bacterial cell wall, disrupting its synthesis and ultimately leading to cell death. - Nuzyra · Paratek Pharms
Nuzyra works by inhibiting protein synthesis in bacteria, ultimately leading to their death. - Orbactiv · Melinta Therap
Orbactiv works by binding to the bacterial cell wall, disrupting its synthesis and ultimately leading to cell death. - Nuzyra · Paratek Pharms
Nuzyra works by inhibiting protein synthesis in bacteria, ultimately leading to their death. - Chlorocidin · Parkedale
- Xydalba · Correvio International Sarl
- Gentamicin · Merck & Co.
- Orbactiv · Melinta Therapeutics, LLC
- Faropenem Daloxate
Faropenem Daloxate works by inhibiting bacterial cell wall synthesis. - Fropenem
Faropenem works by inhibiting bacterial cell wall synthesis, ultimately leading to bacterial cell death. - Baxdela · Melinta
Baxdela works by blocking bacterial enzymes that replicate DNA.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Bacterial infection of skin patent landscape — cliff calendar, originator estates, attackable patents
- Bacterial infection of skin treatment landscape brief
- Bacterial infection of skin treatment updates RSS
Frequently asked questions about Bacterial infection of skin
What drugs treat Bacterial infection of skin?
Tracked treatments include Ramycin, Garamycin, Dalvance, Nuzyra, Orbactiv, Chlorocidin, Xydalba, Gentamicin.
What is the treatment for Bacterial infection of skin?
Standard treatment for Bacterial infection of skin includes Ramycin, Garamycin, Dalvance, Nuzyra, Orbactiv. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Bacterial infection of skin patent cliff · Bacterial infection of skin CI report
- Treatment: Ramycin
- Treatment: Garamycin · Merck & Co.
- Treatment: Dalvance · AbbVie
- Treatment: Nuzyra · Paratek Pharms
- Treatment: Orbactiv · Melinta Therap
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing